Arena Pharmaceuticals, Outpost Medicine Enter into Licensing Agreement for Undisclosed Novel Compound; Arena To Receive $3M In Cash And Equity And Is Eligible To Receive ~$100M In Milestone Payments And Up To Low Double-Digit Royalty